Senior Medical Expert Vaccines

With scientific and medical affairs expertise in pharmaceutical development and vaccination implementation, this consultant wants to offer competencies to drive or counsel the development of new projects and to define the appropriate governance to contribute to strategic growth and risk management.

• Led strategic definition of the Medical Affairs strategy, structure and processes to materialise the repositioning of the company with the acquisition established vaccines and the launch of commercial operations, supporting new asset development and market expansion

• Built a team of recognised key, coordinating with regulators (FDA & EMA) and public-health organisations (WHO, UNICEF, NIH, HERA, GAVI, African CDC, CEPI) to ensure efficient vaccine distribution, data generation and data-driven communication

• Oversaw worldwide launch of a new vaccine

• Transformed Clinical Development to streamline product launch readiness and overseen Phase I-IV studies for several vaccines

• Created the Department of Epidemiology, driving studies that led to label updates

• Redefined the Department of Medical Writing

• Transformed the Global Clinical Safety & Pharmacovigilance function

• Prioritised pipeline projects to guide corporate growth and strategic goals

• Played a significant role in expanding vaccine adoption from 20 countries at the start of the tenure to over 120 countries, aligning global health priorities with corporate growth interests

• Managed product portfolio prioritisation, playing a key role in the decision to divest 2 vaccines